Brief: Addex Therapeutics Files Prospectus Related To Resale Of Up To 4.25 Million ADS
19/08/2022 22:02
Aug 19 (Reuters) - Addex Therapeutics Ltd ADXN.S :
* ADDEX THERAPEUTICS FILES PROSPECTUS RELATED TO RESALE, BY
THE
SELLING SHAREHOLDER IDENTIFIED IN THIS PROSPECTUS, OF UP TO 4.25
MILLION ADS - SEC FILING
Source text for Eikon: [https://bit.ly/3T1qcKq]
Further company coverage: ADXN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand